AbbVie
ABBV
#26
Rank
ยฃ272.84 B
Marketcap
ยฃ154.40
Share price
-0.50%
Change (1 day)
36.17%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total assets

Total assets on the balance sheet as of June 2024 : ยฃ109.84 Billion

According to AbbVie's latest financial reports the company's total assets are ยฃ109.84 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

AbbVie - Total assets on balance sheet (from 2011 to 2024)

Total assets by year

Year Total assets Change
2023-12-31ยฃ105.73 B-7.84%
2022-12-31ยฃ114.73 B5.69%
2021-12-31ยฃ108.55 B-1.73%
2020-12-31ยฃ110.46 B62.54%
2019-12-31ยฃ67.95 B45.34%
2018-12-31ยฃ46.75 B-10.73%
2017-12-31ยฃ52.37 B-2.23%
2016-12-31ยฃ53.56 B49.64%
2015-12-31ยฃ35.79 B102.57%
2014-12-31ยฃ17.67 B-0.17%
2013-12-31ยฃ17.70 B5.93%
2012-12-31ยฃ16.70 B33.05%
2011-12-31ยฃ12.55 B-8.26%
2010-12-31ยฃ13.69 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
ยฃ167.31 B 52.32%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ72.49 B-34.01%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ58.51 B-46.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ70.33 B-35.97%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ41.46 B-62.25%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ20.74 B-81.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ60.12 B-45.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ80.75 B-26.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ2.73 B-97.51%๐Ÿ‡บ๐Ÿ‡ธ USA